Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma
10 December 2019
Launch of Kigabeq® in France
7 January 2020

ORPHELIA Pharma will be present at Toulouse for the thirtieth SFNP congress

ORPHELIA Pharma will be present in Toulouse on January, 15th to 17th, for the SFNP Congress (Société Française de Neuropédiatrie). This event aims to bring together the French community of pediatric neurologists and share latest advances in paediatric neurology. Do not hesitate to contact us in order to meet at this occasion (hugues.bienayme@orphelia-pharma.eu)